Events and presentations Presentations Pyxis Oncology Corporate Presentation – April 2024 PYX-201, EDB+FN is an attractive target in oncology: Insights from protein expression analysis of solid tumors – Abstract Number: 2908 PYX-201, a stroma-targeting ADC composed of an anti-EDB+FN antibody conjugated to Auristatin0101, demonstrates strong anti-tumor efficacy across multiple human cancer indications in pre-clinical PDX tumor models - Abstract Number: 742 PYX-106, Gene expression correlation of immune checkpoint molecules Siglec-15 and PD-L1 varies widely by cancer indication – Abstract Number: 1373 Past events Stifel 2024 Virtual Targeted Oncology Forum Apr 16, 2024 at 1:30 PM EDT Listen to webcast Leerink Partners Global Biopharma Conference 2024 Mar 13, 2024 at 8:40 AM EDT Webcast Jefferies London Healthcare Conference Nov 16, 2023 at 12:30 PM GMT Listen to webcast H.C. Wainwright 25th Annual Global Investment Conference (Virtual) Sep 11, 2023 Wells Fargo Healthcare Conference Sep 6, 2023 BTIG Virtual Biotechnology Conference Aug 7, 2023 at 3:00 PM EDT Jefferies Healthcare Conference Jun 7, 2023 at 4:00 PM EDT Listen to webcast Pyxis Oncology Corporate Update May 24, 2023 at 9:00 AM EDT Listen to webcast Aegis Virtual Conference May 3, 2023 at 1:30 PM EDT Live Zoom
Presentations Pyxis Oncology Corporate Presentation – April 2024 PYX-201, EDB+FN is an attractive target in oncology: Insights from protein expression analysis of solid tumors – Abstract Number: 2908 PYX-201, a stroma-targeting ADC composed of an anti-EDB+FN antibody conjugated to Auristatin0101, demonstrates strong anti-tumor efficacy across multiple human cancer indications in pre-clinical PDX tumor models - Abstract Number: 742 PYX-106, Gene expression correlation of immune checkpoint molecules Siglec-15 and PD-L1 varies widely by cancer indication – Abstract Number: 1373 Past events Stifel 2024 Virtual Targeted Oncology Forum Apr 16, 2024 at 1:30 PM EDT Listen to webcast Leerink Partners Global Biopharma Conference 2024 Mar 13, 2024 at 8:40 AM EDT Webcast Jefferies London Healthcare Conference Nov 16, 2023 at 12:30 PM GMT Listen to webcast H.C. Wainwright 25th Annual Global Investment Conference (Virtual) Sep 11, 2023 Wells Fargo Healthcare Conference Sep 6, 2023 BTIG Virtual Biotechnology Conference Aug 7, 2023 at 3:00 PM EDT Jefferies Healthcare Conference Jun 7, 2023 at 4:00 PM EDT Listen to webcast Pyxis Oncology Corporate Update May 24, 2023 at 9:00 AM EDT Listen to webcast Aegis Virtual Conference May 3, 2023 at 1:30 PM EDT Live Zoom
PYX-201, EDB+FN is an attractive target in oncology: Insights from protein expression analysis of solid tumors – Abstract Number: 2908
PYX-201, a stroma-targeting ADC composed of an anti-EDB+FN antibody conjugated to Auristatin0101, demonstrates strong anti-tumor efficacy across multiple human cancer indications in pre-clinical PDX tumor models - Abstract Number: 742
PYX-106, Gene expression correlation of immune checkpoint molecules Siglec-15 and PD-L1 varies widely by cancer indication – Abstract Number: 1373